![Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression | BMC Psychiatry | Full Text Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression | BMC Psychiatry | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12888-019-2181-9/MediaObjects/12888_2019_2181_Fig2_HTML.png)
Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression | BMC Psychiatry | Full Text
![Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trial - The Lancet Psychiatry Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trial - The Lancet Psychiatry](https://www.thelancet.com/cms/attachment/54131111-0636-4405-8112-24d76b464cfc/gr1_lrg.gif)
Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trial - The Lancet Psychiatry
![P01.132 Safety during long-term exposure to Seroquel® (quetiapine) | European Psychiatry | Cambridge Core P01.132 Safety during long-term exposure to Seroquel® (quetiapine) | European Psychiatry | Cambridge Core](https://static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Aarticle%3AS092493380005152X/resource/name/firstPage-S092493380005152Xa.jpg)
P01.132 Safety during long-term exposure to Seroquel® (quetiapine) | European Psychiatry | Cambridge Core
![Efficacy and Tolerability of Olanzapine, Quetiapine, and Risperidone in the Treatment of Early Psychosis: A Randomized, Double-Blind 52-Week Comparison | American Journal of Psychiatry Efficacy and Tolerability of Olanzapine, Quetiapine, and Risperidone in the Treatment of Early Psychosis: A Randomized, Double-Blind 52-Week Comparison | American Journal of Psychiatry](https://ajp.psychiatryonline.org/cms/10.1176/ajp.2007.164.7.1050/asset/images/medium/r915f1.jpeg)